ULURU Inc.

ADDISON, Texas, May 16, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced its financial results for the first quarter ended March 31, 2013 and provided a review of its operating activities. Based on the first quarter activities, the Company is confirming the previously communicated outlook for 2013: ... read more

ADDISON, Texas, May 7, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the first quarter ended March 31, 2013 financial results and to provide a general business update on Monday, May 20, 2013 at 9:00 a.m. Eastern ... read more

ADDISON, Texas, April 1, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced its financial results for the fourth quarter and year ended December 31, 2012 and provided a review of its operating activities. Significant progress has been made over the past 12 months, including: -- Securing ... read more

ADDISON, Texas, March 25, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the fourth quarter and year ended December 31, 2012 financial results and to provide a general business update on Monday, April 1, 2013 at 9:00 ... read more

ADDISON, Texas, March 18, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today provided a business update and outlook for the balance of 2013. The current focus of our business activities is on the expansion of our global commercialization of Altrazeal(®) in conjunction with Altrazeal Trading Ltd. ... read more

ADDISON, Texas, March 15, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR),a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced the completion of a definitive agreement to sell an aggregate of 1,100,000 shares of its common stock ... read more

ADDISON, Texas, Jan. 21, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) announced today the appointment of Helmut Kerschbaumer and Klaus Kuehne as members of the Board of Directors of ULURU Inc. As part of the previously announced strategic relationship with an affiliate of Melmed Holding AG, IPMD GmbH ... read more

ADDISON, Texas, Jan. 14, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) announced today the availability in the U.S. market of Altrazeal(®) in an innovative 0.75 gram blister pack. The development of this innovative packaging system was in response to requests from wound care practitioners. This packaging configuration overcomes the concerns expressed ... read more

ADDISON, Texas, Jan. 8, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) announced today the first shipment of the 0.75 gram blister pack to our Austrian marketing partner. The extensive clinical experience in Austria has established a significant platform from which to rapidly penetrate this market. Both clinical and ... read more

ADDISON, Texas, Dec. 27, 2012 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU), a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced the completion of a definitive agreement to sell 5,000,000 shares of its common stock at ... read more